4.5 Article

Autofluorescence microscopy: A non-destructive tool to monitor mitochondrial toxicity

期刊

TOXICOLOGY LETTERS
卷 206, 期 3, 页码 281-288

出版社

ELSEVIER IRELAND LTD
DOI: 10.1016/j.toxlet.2011.06.025

关键词

Mitochondrial toxicity; Autofluorescence microscopy; NADH; In vitro toxicity

向作者/读者索取更多资源

Visualization of NADH by fluorescence microscopy makes it possible to distinguish mitochondria inside living cells, allowing structure analysis of these organelles in a non-invasive way. Mitochondrial morphology is determined by the occurrence of mitochondrial fission and fusion. During normal cell function mitochondria appear as elongated tubular structures. However, cellular malfunction induces mitochondria to fragment into punctiform, vesicular structures. This change in morphology is associated with the generation of reactive oxygen species (ROS) and early apoptosis. The aim of this study is to demonstrate that autofluorescence imaging of mitochondria in living eukaryotic cells provides structural and morphological information that can be used to assess mitochondria! health. We firstly established the illumination conditions that do not affect mitochondrial structure and calculated the maximum safe light dose to which the cells can be exposed. Subsequently, sequential recording of mitochondrial fluorescence was performed and changes in mitochondrial morphology were monitored in a continuous non-destructive way. This approach was then used to assess mitochondrial toxicity induced by potential toxicants exposed to mammalian cells. Both mouse and human cells were used to evaluate mitochondrial toxicity of different compounds with different toxicities. This technique constitutes a novel and promising approach to explore chemical induced toxicity because of its reliability to monitor mitochondrial morphology changes and corresponding toxicity in a non-invasive way. (C) 2011 Elsevier Ireland Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Medicine, Research & Experimental

Neutrophil-to-hepatocyte communication via LDLR-dependent miR-223-enriched extracellular vesicle transfer ameliorates nonalcoholic steatohepatitis

Yong He, Robim M. Rodrigues, Xiaolin Wang, Wonhyo Seo, Jing Ma, Seonghwan Hwang, Yaojie Fu, Eszter Trojnar, Csaba Matyas, Suxian Zhao, Ruixue Ren, Dechun Feng, Pal Pacher, George Kunos, Bin Gao

Summary: This study reveals that the elevation of miR-223 in hepatocytes is due to preferential uptake of miR-223-enriched EVs released from neutrophils and other cells, mediated by LDLR and APOE expression. The internalized EV-derived miR-223 acts to inhibit hepatic inflammatory and fibrogenic gene expression, thereby limiting the progression of NASH.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Article Gastroenterology & Hepatology

Interleukin-20 exacerbates acute hepatitis and bacterial infection by downregulating IκBζ target genes in hepatocytes

Yong He, Dechun Feng, Seonghwan Hwang, Bryan Mackowiak, Xiaolin Wang, Xiaogang Xiang, Robim M. Rodrigues, Yaojie Fu, Jing Ma, Tianyi Ren, Yeni Ait-Ahmed, Mingjiang Xu, Suthat Liangpunsakul, Bin Gao

Summary: IL-20 selectively inhibits hepatic IL-6 production rather than exerting IL-10-like broad anti-inflammatory properties. Unlike IL-22, IL-20 aggravates acute hepatitis and bacterial infection. Thus, anti-IL-20 therapy could be a promising option to control acute hepatitis and bacterial infection.

JOURNAL OF HEPATOLOGY (2021)

Review Gastroenterology & Hepatology

Direct reprogramming of somatic cells into induced hepatocytes: Cracking the Enigma code

Matthias Rombaut, Joost Boeckmans, Robim M. Rodrigues, Leo A. van Grunsven, Tamara Vanhaecke, Joery De Kock

Summary: The unmet need for functional primary human hepatocytes has led to the discovery that somatic cells can be directly converted into induced hepatocytes, bypassing the need for an intermediate stem cell state. However, understanding and controlling the processes that give rise to functional induced hepatocytes remains challenging.

JOURNAL OF HEPATOLOGY (2021)

Review Toxicology

Infections at the nexus of metabolic-associated fatty liver disease

Joost Boeckmans, Matthias Rombaut, Thomas Demuyser, Baptist Declerck, Denis Pierard, Vera Rogiers, Joery De Kock, Luc Waumans, Koen Magerman, Reinoud Cartuyvels, Jean-Luc Rummens, Robim M. Rodrigues, Tamara Vanhaecke

Summary: Metabolic-associated fatty liver disease (MAFLD) is a chronic liver disease affecting about a quarter of the global population. Various factors like diet, lifestyle, genetics, drug intake, gender, and infections can accelerate disease progression. Infections can exacerbate pre-existing MAFLD, leading to more severe stages, and the synergistic effects of infections with other factors are emphasized in disease progression.

ARCHIVES OF TOXICOLOGY (2021)

Article Gastroenterology & Hepatology

E-Selectin-Dependent Inflammation and Lipolysis in Adipose Tissue Exacerbate Steatosis-to-NASH Progression via S100A8/9

Robim M. Rodrigues, Yong He, Seonghwan Hwang, Adeline Bertola, Bryan Mackowiak, Yeni Ait Ahmed, Wonhyo Seo, Jing Ma, Xiaolin Wang, Seol Hee Park, Yukun Guan, Yaojie Fu, Tamara Vanhaecke, Dechun Feng, Bin Gao

Summary: This study found that E-selectin induces neutrophil recruitment in adipose tissue, promoting inflammation and lipolysis, thereby exacerbating the progression from steatosis to NASH.

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2022)

Article Biochemistry & Molecular Biology

From NAFLD to MAFLD: Aligning Translational In Vitro Research to Clinical Insights

Alexandra Gatzios, Matthias Rombaut, Karolien Buyl, Joery De Kock, Robim M. Rodrigues, Vera Rogiers, Tamara Vanhaecke, Joost Boeckmans

Summary: The underlying mechanisms of non-alcoholic fatty liver disease (NAFLD) are highly heterogeneous, leading to the proposal of redefining it as metabolic dysfunction-associated fatty liver disease (MAFLD). Patient stratification could accelerate the development of anti-MAFLD drugs, and human-based in vitro models that accurately reflect distinct MAFLD subgroups should be adopted. The current general approach to in vitro NAFLD models is no longer applicable, and considerations for translational in vitro experiments in the MAFLD era are outlined in this review article.

BIOMEDICINES (2022)

Review Pharmacology & Pharmacy

Therapeutic potential of traditional Chinese medicine for the treatment of NAFLD: A promising drug Potentilla discolor Bunge

Longshan Ji, Qian Li, Yong He, Xin Zhang, Zhenhua Zhou, Yating Gao, Miao Fang, Zhuo Yu, Robim M. Rodrigues, Yueqiu Gao, Man Li

Summary: Nonalcoholic fatty liver disease (NAFLD) is a liver disease characterized by excessive accumulation of liver fat and metabolic stress-induced liver injury. Traditional Chinese medicine (TCM) has unique advantages in the treatment of NAFLD. Various TCM formulas, including Potentilla discolor Bunge (PDB), have been reported to improve NAFLD by exhibiting anti-oxidative, anti-inflammatory, and lipid metabolism-improving effects.

ACTA PHARMACEUTICA SINICA B (2022)

Article Cell Biology

Transcriptomics Reveals Discordant Lipid Metabolism Effects between In Vitro Models Exposed to Elafibranor and Liver Samples of NAFLD Patients after Bariatric Surgery

Joost Boeckmans, Alexandra Gatzios, Anja Heymans, Matthias Rombaut, Vera Rogiers, Joery De Kock, Tamara Vanhaecke, Robim M. Rodrigues

Summary: This study characterized the transcriptome of various in vitro models of non-alcoholic steatohepatitis (NASH) and investigated the effects of the potential anti-NASH compound elafibranor on these models. The study found common anti-inflammatory responses in both elafibranor-treated in vitro models and clinical datasets of NAFLD patients after bariatric surgery. However, there were discordant modulations of key factors in lipid metabolism, suggesting the need for further investigation of elafibranor as a potential NASH therapy.
Review Gastroenterology & Hepatology

PNPLA3 I148M and response to treatment for hepatic steatosis: A systematic review

Joost Boeckmans, Alexandra Gatzios, Joern M. Schattenberg, Ger H. Koek, Robim M. Rodrigues, Tamara Vanhaecke

Summary: This study investigates the impact of the PNPLA3 gene mutation on the treatment of non-alcoholic fatty liver disease (NAFLD), finding that carrying the PNPLA3 148M allele may not benefit from omega-3 carboxylic acids to reduce liver fat, while lifestyle changes are more effective for these patients.

LIVER INTERNATIONAL (2023)

Review Pharmacology & Pharmacy

Immune cells and their derived microRNA-enriched extracellular vesicles in nonalcoholic fatty liver diseases: Novel therapeutic targets

Liu Yang, Yawen Hao, Joost Boeckmans, Robim M. Rodrigues, Yong He

Summary: Nonalcoholic fatty liver disease (NAFLD) is a major global cause of chronic liver disease. Despite extensive research and clinical trials, there are no FDA-approved treatments for severe forms of NAFLD due to its complex etiology and pathogenesis. Inflammation and the role of immune cells and extracellular vesicles (EVs) derived from inflammatory cells and hepatocytes are key factors in NAFLD progression. This review focuses on the involvement of immune cells, microRNA-enriched EVs, and potential drug targets in the treatment of NAFLD.

PHARMACOLOGY & THERAPEUTICS (2023)

Editorial Material Toxicology

Pharmacogenetics in early drug development for non-alcoholic steatohepatitis: missed chances and future opportunities

Joost Boeckmans, Alexandra Gatzios, Joern M. Schattenberg, Robim M. Rodrigues, Vera Rogiers, Tamara Vanhaecke

ARCHIVES OF TOXICOLOGY (2023)

Review Public, Environmental & Occupational Health

GENE-OCCUPATION INTERACTIONS : A REVIEW OF THE LITERATURE ON BLADDER AND PROSTATE CANCER

Edyta Wieczorek, Anna Wolniakowska, Joanna Roszak, Robim M. Rodrigues, Tamara Vanhaecke, Edyta Reszka

Summary: Bladder cancer (BCa) and prostate cancer (PCa) are significant health problems in men, and understanding the genetic susceptibility and occupational exposure is crucial for prevention and early detection. This review article identified relevant studies on genetic risk factors and occupational exposure, finding the involvement of genes related to detoxification processes, oxidative stress, DNA repair capacity, tumor suppression, and the vitamin D pathway. While the role of genetic factors in occupational exposure is not conclusive, further research is needed to validate these findings and assess their significance in the workplace.

MEDYCYNA PRACY (2023)

Article Pharmacology & Pharmacy

Human skin stem cell-derived hepatic cells as in vitro drug discovery model for insulin-driven de novo lipogenesis

Karolien Buyl, Martine Vrints, Ruani Fernando, Terry Desmae, Thomas Van Eeckhoutte, Mia Jans, Jan Van Der Schueren, Joost Boeckmans, Robim M. Rodrigues, Veerle De Boe, Vera Rogiers, Joery De Kock, Filip Beirinckx, Tamara Vanhaecke

Summary: This study introduces a novel in vitro human liver cell model for studying metabolic dysfunction-associated steatotic liver disease. The model accurately simulates the insulin-driven pathway of fatty acid synthesis and allows for high-throughput screening of potential therapeutic drugs.

EUROPEAN JOURNAL OF PHARMACOLOGY (2023)

Article Gastroenterology & Hepatology

Deletion of adipocyte prohibitin 1 exacerbates high-fat diet-induced steatosis but not liver inflammation and fibrosis

Xiaolin Wang, Seung-Jin Kim, Yukun Guan, Richard Parker, Robim M. Rodrigues, Dechun Feng, Shelly C. Lu, Bin Gao

Summary: This study reveals the important role of PHB1 in the development and progression of NAFLD. Adipocyte-specific deletion of PHB1 results in increased severity of liver steatosis without obesity, accompanied by reduced adipose tissue inflammation. Liver inflammation and fibrosis in these mice are similar to those in obese NAFLD, partly due to reduced total adipose tissue inflammation and hepatic interferon pathway.

HEPATOLOGY COMMUNICATIONS (2022)

Article Biochemistry & Molecular Biology

Activation of VIPR1 suppresses hepatocellular carcinoma progression by regulating arginine and pyrimidine metabolism

Yaojie Fu, Shanshan Liu, Robim M. Rodrigues, Ying Han, Cao Guo, Zhanwei Zhu, Yong He, Bryan Mackowiak, Dechun Feng, Bin Gao, Shan Zeng, Hong Shen

Summary: This study explored the role of VIP/VIPR1 signaling in controlling hepatocellular carcinoma (HCC). VIPR1 expression was found to be downregulated in HCC tissues and correlated with advanced clinical stages, tumor growth, recurrence, and poor outcomes. Activation of VIPR1 by VIP inhibited HCC growth and metastasis by regulating arginine biosynthesis. Mechanistically, VIP treatment restored ASS1 expression and suppressed CAD phosphorylation in an mTOR/p70S6K signaling dependent manner. Restoring VIPR1 and using VIPR1 agonists may be a promising approach in HCC treatment.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2022)

暂无数据